Cue Biopharma

-$2.61 (-24.62%) Today

+$0.29 (+3.63%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease.

CEO

Daniel R. Passeri

Employees

Headquarters

Cambridge, Massachusetts

Founded

2014

CUE Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

565.37K

High today

$9.99

Low today

$7.19

Open price

$9.99

Volume

1.65M

52 Week high

$18.42

52 Week low

$7.19

CUE News

Benzinga14h

Cue Pharma Posts Two Responses From CUE-101 Combo In Head & Neck Cancer

Early data from a trial evaluating Cue Biopharma Inc's (NASDAQ: CUE) CUE-101 combined with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) demonstrated th

Analyst ratings

Buy

100%

Hold

Sell

CUE Earnings

-$0.42

-$0.28

-$0.14

-$0.00

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Mar 8, After Hours